Moderna (MRNA) Reports Interim Data From Phase 1 Study of mRNA-2752 Triplet Program
Go back to Moderna (MRNA) Reports Interim Data From Phase 1 Study of mRNA-2752 Triplet Program| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.53 -0.89 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.42 | 52 Week High | $0.52 | |||
| Open | $60.33 | 52 Week Low | $0.08 | |||
| Day High | $61.52 | P/E | N/A | |||
| Day Low | $59.18 | EPS | $-3.80 | |||
| Volume | 590,865 | |||||
